Reprint
Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. Gösta Gahrton
Edited by
January 2022
124 pages
- ISBN978-3-0365-2906-6 (Hardback)
- ISBN978-3-0365-2907-3 (PDF)
This is a Reprint of the Special Issue Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. Gösta Gahrton that was published in
Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary
Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this hematological malignancy.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
multiple myeloma; immunotherapy; daratumumab; BCMA; bi-specific T cell engagers; chimeric antigen receptor; relapse; cytokine-release syndrome; allogeneic transplantation; myeloablative; non-myeloablative; multiple myeloma; new drugs; CAR T; multiple myeloma; immunotherapy; antibodies; monoclonal; bispecific; immunoconjugates; antibody-drug conjugates; myeloma; NK cells; immunomodulation; cell therapy; immunotherapy; graft-versus-myeloma; donor lymphocyte infusion; myeloma; allogeneic stem cell transplantation; prophylaxis; salvage; relapse; myeloma; CAR T-cells; target antigen; n/a